Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 Channels.
Koch SE, Nieman ML, Robbins N, Slone S, Worley M, Green LC, Chen Y, Barlow A, Tranter M, Wang H, Lorenz JN, Rubinstein J. Koch SE, et al. Among authors: robbins n. J Cardiovasc Pharmacol. 2018 Jul;72(1):40-48. doi: 10.1097/FJC.0000000000000588. J Cardiovasc Pharmacol. 2018. PMID: 29688911 Free PMC article.
The history and future of probenecid.
Robbins N, Koch SE, Tranter M, Rubinstein J. Robbins N, et al. Cardiovasc Toxicol. 2012 Mar;12(1):1-9. doi: 10.1007/s12012-011-9145-8. Cardiovasc Toxicol. 2012. PMID: 21938493 Review.
Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.
Koch SE, Tranter M, Robbins N, Luther K, Singh U, Jiang M, Ren X, Tee T, Smith L, Varma P, Jones WK, Rubinstein J. Koch SE, et al. Among authors: robbins n. J Cardiovasc Pharmacol Ther. 2013 May;18(3):280-9. doi: 10.1177/1074248412469299. Epub 2012 Dec 14. J Cardiovasc Pharmacol Ther. 2013. PMID: 23241275 Free PMC article.
Tefillin use induces remote ischemic preconditioning pathways in healthy men.
Owens AP 3rd, Robbins N, Saum K, Jones SM, Kirschner A, Woo JG, McCoy C, Slone S, Rothenberg ME, Urbina EM, Tranter M, Rubinstein J. Owens AP 3rd, et al. Among authors: robbins n. Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1748-H1758. doi: 10.1152/ajpheart.00347.2018. Epub 2018 Sep 14. Am J Physiol Heart Circ Physiol. 2018. PMID: 30216115 Free PMC article.
Human antigen R as a therapeutic target in pathological cardiac hypertrophy.
Green LC, Anthony SR, Slone S, Lanzillotta L, Nieman ML, Wu X, Robbins N, Jones SM, Roy S, Owens AP 3rd, Aube J, Xu L, Lorenz JN, Blaxall BC, Rubinstein J, Benoit JB, Tranter M. Green LC, et al. Among authors: robbins n. JCI Insight. 2019 Feb 21;4(4):e121541. doi: 10.1172/jci.insight.121541. eCollection 2019 Feb 21. JCI Insight. 2019. PMID: 30668549 Free PMC article.
Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance.
Rubinstein J, Lasko VM, Koch SE, Singh VP, Carreira V, Robbins N, Patel AR, Jiang M, Bidwell P, Kranias EG, Jones WK, Lorenz JN. Rubinstein J, et al. Among authors: robbins n. Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H574-84. doi: 10.1152/ajpheart.00854.2013. Epub 2013 Dec 6. Am J Physiol Heart Circ Physiol. 2014. PMID: 24322617 Free PMC article.
280 results